Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome
Recommended Citation
Hencken L, To L, Ly N, and Morgan JA. Serotonin syndrome following methylene blue administration for vasoplegic syndrome J Card Surg 2016; 31(4):208-210.
Document Type
Article
Publication Date
4-1-2016
Publication Title
Journal of cardiac surgery
Keywords
Citalopram/adverse effects, Drug Synergism, Female, Heart-Assist Devices, Humans, Methylene Blue/administration & dosage/adverse effects, Middle Aged, Prosthesis Implantation, Serotonin Syndrome/chemically induced, Selective Serotonin Reuptake Inhibitors/adverse effects, Severity of Illness Index, Vasoplegia/therapy
Abstract
Methylene blue (MB) has been used for additional blood pressure support in patients who develop severe, refractory vasoplegia; however, MB can induce serotonin syndrome, especially when used in conjunction with other serotonergic agents. We describe a case of serotonin syndrome in a patient who received MB for vasoplegic syndrome after left ventricular assist device implantation and discuss its presentation and management.
Medical Subject Headings
Citalopram/adverse effects; Drug Synergism; Female; Heart-Assist Devices; Humans; Methylene Blue/administration & dosage/adverse effects; Middle Aged; Prosthesis Implantation; Serotonin Syndrome/chemically induced; Selective Serotonin Reuptake Inhibitors/adverse effects; Severity of Illness Index; Vasoplegia/therapy
PubMed ID
26934199
Volume
31
Issue
4
First Page
208
Last Page
210
